Fitzpatrick Alexander A 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
- Award
Stock option (right to buy)
2024-01-02+300,000→ 300,000 totalExercise: $5.58Exp: 2034-01-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.